Clinical-grade Recombinant Proteins for Cell Therapy
High quality StemFit Purotein® recombinant proteins have been selected for their key roles in differentiating stem cells into liver, pancreas, kidney, heart, blood, and immune cells.

Laboratory products

Clinical-grade Recombinant Proteins for Cell Therapy

04 May, 2022

Published over 4 years ago. See the latest and most current information on Laboratory products.

The demand for cell therapy grade proteins

Continued expansion of cell therapy applications across healthcare and the life sciences is driving a rapidly increasing need for clinically applicable ancillary materials. A key requirement is for recombinant proteins, such as growth factors and cytokines. This demand for clinically applicable recombinant proteins places stringent requirements on product quality, lot-to-lot consistency, and compliance with all relevant laws and regulations.

StemFit Purotein® from AMSBIO are a range of high purity, high activity recombinant proteins for cell therapy applications.

Animal-origin free, high purity GMP-grade recombinant proteins

All StemFit Purotein® products are designed and manufactured under a strict animal-free protocol which minimises risk of virus contamination and ensures high lot-to-lot consistency. Manufactured using a streamlined (optionally GMP compliant) production and purification process results in recombinant proteins of the highest purity and quality while maintaining affordable prices. The StemFit Purotein® range includes recombinant proteins that play key roles in differentiation of ES and iPS cells into liver, pancreas, kidney, heart, blood, and immune cells. Beneficially, StemFit Purotein® products are supplied in a ‘ready-to-use’ frozen liquid form which eliminates the time-consuming process of reconstitution while ensuring consistent results.

Purotein® products are fully compatible with the StemFit® range of xeno-free, chemically defined media which is proven to effectively maintain induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) under feeder-free conditions during the reprogramming, expansion and differentiation phases of stem cell culture and growth medium.

More information online

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Mercury emissions monitoring for environmental compliance
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Dr. Raj Shah receives NLGI Achievement Award, adding to a distinguished career in fuels, lubricants and petroleum testing
Explore more Arrow
Chromatography Today
Novogene Europe adds untargeted metabolomics service in Cambridge
Explore more Arrow